ObjectivesTo evaluate the efficacy and safety of certolizumab pegol (CZP) after 24 weeks in RAPID-axSpA (NCT01087762), an ongoing Phase 3 trial in patients with axial spondyloarthritis (axSpA), including patients with ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA).MethodsPatients with active axSpA were randomised 1:1:1 to placebo, CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W). In total 325 patients were randomised. Primary endpoint was ASAS20 (Assessment of SpondyloArthritis international Society 20) response at week 12. Secondary outcomes included change from baseline in Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Bath Ankylosing Spondylitis Metrology Index (BASMI) linear.ResultsBaseline disease activity was similar between AS and nr-axSpA. At week 12, ASAS20 response rates were significantly higher in CZP 200 mg Q2W and CZP 400 mg Q4W arms versus placebo (57.7 and 63.6 vs 38.3, p≤0.004). At week 24, combined CZP arms showed significant (p<0.001) differences in change from baseline versus placebo in BASFI (−2.28 vs −0.40), BASDAI (−3.05 vs −1.05), and BASMI (−0.52 vs −0.07). Improvements were observed as early as week 1. Similar improvements were reported with CZP versus placebo in both AS and nr-axSpA subpopulations. Adverse events were reported in 70.4% vs 62.6%, and serious adverse events in 4.7% vs 4.7% of All CZP versus placebo groups. No deaths or malignancies were reported.ConclusionsCZP rapidly reduced the signs and symptoms of axSpA, with no new safety signals observed compared to the safety profile of CZP in RA. Similar improvements were observed across CZP dosing regimens, and in AS and nr-axSpA patients.
The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Cover design: deblik, BerlinPrinted on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) To my family and Carolin ForewordOur planet is permanently vibrating, excited by oceans, atmosphere, earthquakes, or man-made sources. Luckily, Earth's physical properties are such that these vibrations -elastic waves to be more specific -often propagate to large distances carrying information on the medium they encounter along the way. The problem of making an educated guess at the subsurface structure from observations of ground motions is as old as instrumental seismology itself (so not that old, maybe a century or so). Let us call the problem seismic tomography akin to CT scanning in medicine, a field seismologists have always envied. Because of limitations in illuminating the Earth with sufficient coverage we have never obtained the sharp and detailed internal structures so familiar from medical imaging.Up to now we have mostly cut corners in the way we model and fit our seismic data. We typically reduce long, wiggly seismograms to a few bytes of information (e.g. travel times, phase velocities) and try to explain these data with approximate theories. This has been for a good reason. Our computers were simply not fast and big enough to allow the calculation of complete wave fields through 3D Earth structures. Frequently the data just do not warrant the use of sophisticated physics.The situation regarding computational power in connection with 3D wave propagation has dramatically changed in the past few years. Even on a global scale the calculation of wave fields across the complete observed frequency range is in sight. On smaller scales (continents, basins, volcanoes, reservoirs) we are already witnessing the emergence of 3D wave propagation as the tool for data modelling, inversion and parameter studies.This was Albert Tarantola's (and others) dream 25 years ago: just simulate the physics correctly and let the data (i.e. the misfit to a theoretical seismogram) decide whether the Earth model is good or not. In his world (the probabilistic approach) this should be done using a Monte Carlo-type approach: calculate zillions of models and use all the results to estimate parameters and uncertainties. Unfortunately, we are not there yet. We still need to resort to linearisations around (hopefully good) starting models and employ adjoint-type techniques to update our Earth models. Fortunately, in many situations, good starting models can be found, making iterative waveform inversion the preferred tool to improve our Earth models using most or all of the observed data. vii viii ForewordThe book in your hands is the first to provide a broad overview on how to solve the forward problem to calculate accurate seismograms in 3D Earth m...
S U M M A R YWe present a full seismic waveform tomography for upper-mantle structure in the Australasian region. Our method is based on spectral-element simulations of seismic wave propagation in 3-D heterogeneous earth models. The accurate solution of the forward problem ensures that waveform misfits are solely due to as yet undiscovered Earth structure and imprecise source descriptions, thus leading to more realistic tomographic images and source parameter estimates. To reduce the computational costs, we implement a long-wavelength equivalent crustal model. We quantify differences between the observed and the synthetic waveforms using time-frequency (TF) misfits. Their principal advantages are the separation of phase and amplitude misfits, the exploitation of complete waveform information and a quasi-linear relation to 3-D Earth structure. Fréchet kernels for the TF misfits are computed via the adjoint method. We propose a simple data compression scheme and an accuracy-adaptive time integration of the wavefields that allows us to reduce the storage requirements of the adjoint method by almost two orders of magnitude.To minimize the waveform phase misfit, we implement a pre-conditioned conjugate gradient algorithm. Amplitude information is incorporated indirectly by a restricted line search. This ensures that the cumulative envelope misfit does not increase during the inversion. An efficient pre-conditioner is found empirically through numerical experiments. It prevents the concentration of structural heterogeneity near the sources and receivers.We apply our waveform tomographic method to ≈1000 high-quality vertical-component seismograms, recorded in the Australasian region between 1993 and 2008. The waveforms comprise fundamental-and higher-mode surface and long-period S body waves in the period range from 50 to 200 s. To improve the convergence of the algorithm, we implement a 3-D initial model that contains the long-wavelength features of the Australasian region. Resolution tests indicate that our algorithm converges after around 10 iterations and that both long-and short-wavelength features in the uppermost mantle are well resolved. There is evidence for effects related to the non-linearity in the inversion procedure.After 11 iterations we fit the data waveforms acceptably well; with no significant further improvements to be expected. During the inversion the total fitted seismogram length increases by 46 per cent, providing a clear indication of the efficiency and consistency of the iterative optimization algorithm. The resulting SV -wave velocity model reveals structural features of the Australasian upper mantle with great detail. We confirm the existence of a pronounced low-velocity band along the eastern margin of the continent that can be clearly distinguished against Precambrian Australia and the microcontinental Lord Howe Rise. The transition from Precambrian to Phanerozoic Australia (the Tasman Line) appears to be sharp down to at least 200 km depth. It mostly occurs further east of where it is infe...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.